On March 23, 2022, Humana Inc. completed a public offering of $750 million aggregate principal amount of its 3.700% Senior Notes due 2029. The Senior Notes were issued under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”) (the “Original Indenture”), as supplemented by a twenty-first supplemental indenture, dated as of March 23, 2022, by and between the Company and the Trustee relating to the Senior Notes (the “Twenty-First Supplemental Indenture” and, together with the Original Indenture, the “Indenture”). The sale of the Senior Notes has been registered with the Securities and Exchange Commission (the “Commission”) in a registration statement on Form S-3, File No.

333-254041 (the “Registration Statement”). The terms of the Senior Notes are described in the Company's Prospectus dated March 9, 2021, as supplemented by a final Prospectus Supplement dated March 21, 2022 as filed with the Commission on March 22, 2022, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended.